NF-κΒ activator 1

CAS No. 2387524-59-4

NF-κΒ activator 1( —— )

Catalog No. M35172 CAS No. 2387524-59-4

NF-κΒ activator 1 can activate the nf-kappa Β gene activator, EC50 of 0.9 microns.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 223 In Stock
5MG 202 In Stock
10MG 330 In Stock
25MG 560 In Stock
50MG 783 In Stock
100MG 1079 In Stock
200MG Get Quote In Stock
500MG 2167 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NF-κΒ activator 1
  • Note
    Research use only, not for human use.
  • Brief Description
    NF-κΒ activator 1 can activate the nf-kappa Β gene activator, EC50 of 0.9 microns.
  • Description
    NF-κΒ activator 1 is a potent NF-κΒ activator with an EC50 of 0.9 μM. NF-κΒ activator 1 induces superoxide dismutase (SOD)2 mRNA expression.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    NF-κB
  • Recptor
    NF-κB
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2387524-59-4
  • Formula Weight
    314.33
  • Molecular Formula
    C16H11FN2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (318.14 mM; Ultrasonic )
  • SMILES
    OC(=O)c1cccc(c1)-c1csc(Nc2ccccc2F)n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mathew B, et al. Structure-activity relationship (SAR) studies of N-(3-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (SRI-22819) as NF-?B activators for the treatment of ALS [published online ahead of print, 2020 Oct 22]. Eur J Med Chem. 2020;112952.?
molnova catalog
related products
  • NF-κB/MAPK-IN-1

    NF-κB/MAPK-IN-1 is a potent dual inhibitor of the NF-κB and MAPK pathways with potential anti-inflammatory activity, inhibition of NO production, and inhibition of LPS-induced activation of iNOS, COX-2, ERΚ and P38.

  • CDDO-dhTFEA

    CDDO-dhTFEA is a synthetic oleanane triterpenoid compound which potently activates Nrf2 and inhibits the pro-inflammatory transcription factor NF-κB.?

  • Kukoamine A

    Kukoamine A possesses anticancer, cytoprotective, antioxidant, and anti-inflammatory activities, and inhibits trypanothione reductase as a mixed inhibitor (Ki = 1.8 microM).